- $1.74bn
- $4.88bn
- $6.89bn
- 79
- 91
- 47
- 84
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,066 | 7,022 | 7,038 | 7,107 | 6,886 |
Cost of Revenue | |||||
Gross Profit | 3,650 | 2,626 | 2,423 | 2,318 | 2,314 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8,140 | 6,753 | 7,539 | 7,414 | 6,860 |
Operating Profit | 926 | 269 | -501 | -307 | 26 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 822 | 252 | -475 | -328 | -28 |
Provision for Income Taxes | |||||
Net Income After Taxes | 608 | 188 | -458 | -325 | 1 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,353 | 192 | -455 | -322 | 1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,339 | 178 | -469 | -336 | -13 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.2 | 1.64 | 0.332 | -0.225 | 2.05 |
Dividends per Share |